0001209191-23-026725.txt : 20230502 0001209191-23-026725.hdr.sgml : 20230502 20230502184412 ACCESSION NUMBER: 0001209191-23-026725 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230501 FILED AS OF DATE: 20230502 DATE AS OF CHANGE: 20230502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LYONS GARY A CENTRAL INDEX KEY: 0001123343 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36620 FILM NUMBER: 23881020 MAIL ADDRESS: STREET 1: 12790 EL CAMINO REAL STREET 2: C/O NEUROCRINE BIOSCIENCES CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eledon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 949-238-8090 MAIL ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: Novus Therapeutics, Inc. DATE OF NAME CHANGE: 20170511 FORMER COMPANY: FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc DATE OF NAME CHANGE: 20070622 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-01 0 0001404281 Eledon Pharmaceuticals, Inc. ELDN 0001123343 LYONS GARY A C/O ELEDON PHARMACEUTICALS, INC. 19900 MACARTHUR BLVD STE. 550 IRVINE CA 92612 1 0 0 0 0 Common Stock 2.30 2023-05-01 4 A 0 150437 0.00 A 2033-05-01 Common Stock 150437 150437 D This option represents a right to purchase up to 150,437 shares of Common Stock, which option vests with respect to 75,219 shares on May 1, 2024 and with respect to 75,218 shares on May 1, 2025. /s/ Gary Lyons 2023-05-02